Position in JNJ
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$3,270,879
-$286,700 QoQ
Shares Held
12,879
-11.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.07%
of 13F equity value
Holder Rank
#1,932
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Banco de Sabadell, S.A holds $14,969,128 across 7 Drug Manufacturers - General names. JNJ ranks #2 (21.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,248 | $5,095,179 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
12,879 | $3,270,879 | |
| 3 | AMGN |
Amgen Inc
|
6,877 | $2,490,299 | |
| 4 | MRK |
Merck & Co., Inc.
|
11,969 | $1,538,016 | |
| 5 | NVO |
Novo Nordisk A S
|
18,330 | $878,740 | |
| 6 | SNY |
Sanofi
|
20,466 | $873,079 | |
| 7 | NVS |
Novartis AG
|
5,251 | $822,936 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,270,879 | 12,879 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $3,557,579 | 14,554 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $3,122,461 | 15,088 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $2,854,911 | 15,397 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,376,179 | 15,556 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,565,213 | 15,468 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,120,129 | 14,660 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,346,466 | 14,479 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,735,942 | 11,877 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,871,545 | 11,831 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,072,416 | 13,222 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,141,873 | 13,752 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,421,061 | 14,627 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,144,890 | 13,838 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,261,364 | 13,598 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,304,029 | 14,104 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,476,974 | 13,954 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,414,512 | 19,266 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,187,546 | 18,633 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,846,601 | 29,318 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $1,887,096 | 11,455 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,085,012 | 18,771 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,763,277 | 17,558 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $6,060,606 | 40,708 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,356,455 | 38,089 | Shares | Defined | 2020-08-07 | |
| 2020-03-31 | $1,835,950 | 14,001 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||